9-(5-O-Phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine(CAS: 29984-33-6)

Regulatory guidelines for 9-(5-O-Phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine (CAS: 29984-33-6) include GHS classification for hazardous materials, REACH regulations in the European Union, and FDA and EPA requirements for pharmaceutical and environmental safety. These guidelines ensure the safe handling, storage, and disposal of the compound.

In the synthesis of nucleosides, there are alternatives to 9-(5-O-Phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine (CAS: 29984-33-6), such as using other sugar analogs like 2-deoxy or 2-fluoro sugar derivatives, or employing different phosphoramidite reagents. These alternatives offer varying levels of reactivity and selectivity in the synthesis process.

The research trend for 9-(5-O-Phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine (CAS: 29984-33-6) focuses on its potential as a nucleoside analog for therapeutic applications, particularly in antiviral treatments. Market trends indicate increasing interest in nucleoside-based drugs, driven by advancements in molecular biology and the need for new antiviral therapies.

Waste containing 9-(5-O-Phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine (CAS: 29984-33-6) should be collected in appropriate containers and stored under controlled conditions. It should then be incinerated or disposed of through professional waste disposal services that meet regulatory standards. Environmental precautions include thorough neutralization and detoxification before disposal to prevent contamination.